Binzhou NeoPhar Pharmaceutical co.,ltd located in Binbei industrical park, Shandong province. The producing area covering 20 thousand square meters, mainly engaged in developing and producing pharmaceutical intermediates and meticulous chemical products. Binzhou NeoPhar pharmaceutical has a normative systerm of develop, production and quality. We provided with the international market.
Advantages of R&D
1 Process design based on the concept of QbD & Green chemistry to strengthen in-process quality control and EHS compliance.
2 Comprehensive quality research system which can meet the registration requirements in both Chinese and main regulatory markets(USA,EU,etc).
3 Experienced in patent challenging on polymorphism form and synthesis process of APIs.
Advantages of facility
1)10production lines and 2 independent clean areas for regular APIs with reaction volume 50-5000L.
2)OEB-4 workshop equipped with 4 production lines and 1 clean area,reaction volume 20-1000L.
3)3 special reaction production lines, equipped with devices which suitable for danerous processes.
4)Reaction temperature:-100-250Pressure range:0-8MPa.


CDMO successful cases:
1) One National Class 1 New drugs(NCE) had been approved in 2021,realizing commercial supply of API.
2) Process validation of one patent challenge project has been successfully completed, and ASMF to be filed in EU by middle of 2023.